Cx Precision Medicine provides diagnostic screening services intended to provide a path to drug approval during clinical trials.
Cx Precision Medicine has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in December 2022.
Cx Precision Medicine's investors include Hi2 Venture Fund.
Cx Precision Medicine is headquartered in Fort Worth, United States.
Cx Precision Medicine provides diagnostic screening services intended to provide a path to drug approval during clinical trials.
Cx Precision Medicine is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cx Precision Medicine — Funding & Investors." VCBacked, December 12, 2022, https://www.vcbacked.co/company/cx-precision-medicine. Accessed August 16, 2026.
VCBacked. (2022). Cx Precision Medicine — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/cx-precision-medicine
{{cite web |title=Cx Precision Medicine — Funding & Investors |url=https://www.vcbacked.co/company/cx-precision-medicine |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated